Biobanking Market Emerging Growth Rate, Application, Market Share And Forecast To 2030. The global biobanking market is estimated to be over US$ 2.1 Billion in 2019. It is anticipated to grow at 7.5% CAGR from 2019 to 2030.
New York, NY -- (SBWIRE) -- 04/06/2020 -- Biobanking is the process of collecting samples of bodily fluids or tissues for extensive research and understanding the cause of various diseases. Researchers can also gain information on the things like weight and height that are related to health. The 'bank' term refers to the storage system of samples for research in future. With the help of biobanking samples, researchers can also track the diseases of their patients by studying their past medical records. The targeted process holds significance in cancer research, for the development of personalized medicine, for the making of more precise medicine, greater impact on medical innovation and biotechnology, and carries importance in exchanges and networking between biobanks.
Top Players are:
Some prominent players in the biobanking market include Thermo Fisher Scientific Inc., PHC Holdings Corporation, QIAGEN, Becton, Dickinson and Company, Merck KGaA, Hamilton Company, Tecan Trading AG, Cell&Co, Promega Corporation and Brooks Life Sciences among others.
Get Access to Free Sample Pages @ https://www.marketindustryreports.com/pdf/76
The increasing international awareness for the need of biobanking is promoting the growth of biobanking market. Biobanking plays an important role in advancing biomedical and translational research by providing better opportunities for collection and preservation of biological samples such as blood, tissues, and nucleic acids which are used in research endeavors to discover disease-relevant biomarkers. Moreover, several pharmaceutical companies are investing extensively in drug discovery and developing their pipeline products which requires the application of biobanking. For instance, Novo Nordisk with the support of UK Biobank is discovering novel drug targets for several chronic conditions such as diabetes, cardiovascular liver, kidney diseases and obesity.
Asia Pacific is estimated to account for the highest CAGR in biobanking market over forecast period. The improving research infrastructure, emergence of diseases, and increasing adoption of new technologies in this region is contributing to the growth of biobanking market. Moreover, extensive government initiative and investment for development of novel pharmaceutical products is attributed to increasing use of biobanking.
Get Free Customization @ https://www.marketindustryreports.com/free-customization/76
Table of Content:
GLOBAL BIOBANKING MARKET – ANALYSIS & FORECAST, BY PRODUCT & SERVICE
Sample Processing Equipment
Sample Analysis Equipment
Sample Transport Equipment
Services & Software
GLOBAL BIOBANKING MARKET – ANALYSIS & FORECAST, BY SAMPLE TYPE
GLOBAL BIOBANKING MARKET – ANALYSIS & FORECAST, BY STORAGE TYPE
GLOBAL BIOBANKING MARKET – ANALYSIS & FORECAST, BY APPLICATION
Life Science Research
Get Interesting Discount @ https://www.marketindustryreports.com/discount/76
About Market Industry Reports:
Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
Phone: + 91 8956767535